• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Zimmer Biomet loses appeal on $3.5M hip implant suit verdict

Zimmer Biomet loses appeal on $3.5M hip implant suit verdict

August 26, 2022 By Sean Whooley

Unsplash image of a gavel to go along with lawsuit story
[Image from Unsplash]
A U.S. Court of Appeals denied an appeal from Zimmer Biomet (NYSE:ZBH) to move to a new trial after a $3.5 million hip implant lawsuit verdict.

In 2020, a federal jury in Iowa awarded $3.55 million to Lori Nicholson and her husband Willis for injuries sustained as a result of the company’s much-litigated M2a Magnum metal-on-metal hip implant. The jury found  in Nicholson’s favor following the conclusion that the M2a Magnum was defectively designed. Around the same time as the Iowa lawsuit, a federal judge in Missouri signed off on a $21 million judgment regarding the M2A Magnum.

Zimmer Biomet moved for a new trial and renewed its motion for judgment as a matter of law, but the district court denied these motions and, in a decision filed Aug. 24, the U.S. Court of Appeals for the Eight Circuit affirmed that denial.

The appeals court found that the district court did not err in denying Zimmer Biomet’s motion for judgment as a matter of law on the punitive damages that totaled $3.55 million, determining that, “viewing the evidence in the light most favorable to the verdict,” a reasonable jury could have decided in favor of Nicholson.

Zimmer Biomet argued that the district court abused its discretion in failing to instruct the jury that the M2a Magnum’s instructions and warnings were “adequate as a matter of law.” The company argued that the omission of the instruction “was erroneous” as Iowa’s Civil Jury Instruction 1000.4 lists such instructions and warnings as a factor to consider in assessing “whether a product was reasonably safe.’”

According to the court, Nicholson admits that warnings and instructions are listed as a factor that could have instructed the jury. However, Nicholson said the court was not required to include the factor because evidence and issues presented to the jury did not involve the adequacy of the hip implant’s warnings and instructions. The appeals court agreed.

Metal-on-metal implants represent a notable failure of the medical device industry in the early 21st century. The hip implants were designed to be stronger and more durable, but they instead have been enveloped by higher failure rates and potential exposure to toxins from metal particles released by friction.

The FDA in 2016 mandated PMAs for metal-on-metal hip implants, and there are presently no FDA-approved metal-on-metal total hip replacement devices marketed in the U.S.

Filed Under: Business/Financial News, Featured, Implants, Legal News, Metal-on-Metal, Orthopedics, Product Liability Tagged With: Zimmer Biomet

More recent news

  • Terumo Neuro launches new stroke catheter in the U.S.
  • EnVVeno has first-in-human heart valve data, expects FDA decision this year
  • Axoft makes Fleuron BCI material available for purchase, inks license deal with Stanford
  • BD files patent infringement lawsuit against Baxter over infusion pump tech
  • Tandem Diabetes Care subsidiary earns new FDA clearance for insulin infusion set

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy